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Introduction
Sporadic Creutzfeldt-Jakob disease (CJD) is diagnosed
on the basis of clinical criteria, characteristic EEG signs,
and neuropathological abnormalities demonstrated by
light microscopy and immunohistochemistry. Clinical
criteria are progressive dementia, myoclonus, visual or
cerebellar disturbances, pyramidal or extrapyramidal
features, and characteristic EEG abnormalities [1, 2],
while neuropathological criteria are morphologic
changes on light-microscopy with trias spongiform de-
generation, neuronal loss, and astrocytic gliosis [3]. The
[4] premortem diagnosis of CJD is supported by the
presence of 14-3-3 protein [4] and radiological abnor-
malities, such as hyperintense signals on T1-, T2-,
and/or diffusion weighted MRI images [5–8].
We describe a patient of histopathologically con-
firmed Creutzfeldt-Jakob disease, who had MRI and
pathological lesions at similar localizations and looked
for correlation between the degree of severity of radio-
logical and neuropathological findings.
Clinical history
A 48-year-old woman, without familial or personal his-
tory of neurological disease or transplantation or hor-
mone treatment except contraception, initially pre-
sented with problems of comprehension and memory.
On admission to the Neurology Department six months
after the first symptoms, neuropsychological examina-
tion showed intermittent disorientation, speech disor-
ders with comprehension deficits, dyspraxia, and frontal
signs. Neurological examination showed right visual
hemiextinction, saccadic pursuit, augmentation of mus-
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■ Abstract To investigate a possi-
ble relationship between the sever-
ity of pathological and radiological
lesions in diffusion-weighted MRI
(DWI) we compared DWI findings
from 6 sequential brain MRI scans
with pathological features of nu-
merous tissue blocks of different
cortical and subcortical regions in
a case of autopsy-proven sporadic
CJD. Whereas DWI and pathologi-
cal examination revealed multifo-
cal, cortical and deep hyperintensi-
ties at corresponding localizations,
no correlation between the degree
of severity of radiologically visible
and pathological damage was
found.
The characteristic focal involve-
ment and extension of lesions of
the cortex and the basal ganglia bi-
laterally shown by DWI may be an
argument for the spreading of the
disease per contiguitatem.
■ Key words Creutzfeldt-Jakob
disease · current diagnostic criteria
for clinical diagnosis · diffusion-
weighted MRI · cerebral spongiosis
· gliosis
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cle tone, asterixis and spontaneous myoclonus, ataxia,
and gait disorder with titubation.Laboratory blood tests
revealed a slight inflammatory reaction and high titers
of anti-thyroglobulin and anti-microsomal antibodies
with normal TSH and FT4 values, leading to the diagno-
sis of Hashimoto’s thyroiditis. There were no other ab-
normalities on extensive laboratory and radiological
screening. CSF examination was normal except for the
presence of 14-3-3 protein.
Despite treatment with steroids and immunosup-
pressors, which led to a decrease in anti-microsomal an-
tibody titers, the patient developed akinetic mutism
during the first ten days of hospitalization. Death oc-
curred two months after admission, eleven months after
the first symptoms. The EEG showed periodic triphasic
complexes with loss of background activity and the
presence of intermittent epileptic activity.
Radiology
The patient underwent conventional sagittal and trans-
verse spin echo for T1-WI, T2-WI and proton density-
weighted images of 5-mm thickness using a Siemens
Magnetom 63SP 1.5 T. Matrix was 256  256, and field of
view was 230 mm. Contrast-enhanced T1-WI sagittal
and transverse 5-mm-thick MRI slices were obtained
using gadolinium-diethylenetriamine-pentaacetic acid.
Diffusion weighted (DW) sequences were performed
using a single shot spin-echo planar imaging technique,
giving a diffusion weighting (b-value) of 1100 s/mm2.
The diffusion gradient was applied in the transverse
(x) direction. In selected procedures we also applied the
diffusion gradient in the sagittal and coronal directions
to rule out normal anisotropy. Apparent diffusion coef-
ficient (ADC) was calculated for 11 regions of interest.
Six DW MRI scans (days 1; 7; 21; 31; 38; 46) were per-
formed during hospitalization, the last one six weeks be-
fore the death of the patient.The first one (day 1) showed
focal signal hyperintensities localized in the left frontal
cortex, the parietal cortex bilaterally, with left predomi-
nance, the head of the caudate with left predominance,
the cingulate gyrus, the anterior part of the left puta-
men, and the left temporal cortex. There was extension
and intensification of signal hyperintensities in the head
of the right caudate and the right parietal cortex on the
MRI-scan (2) one week later. On day 21 (3) there was in-
tensification of the previously described hypersignals in
the left caudate nucleus and left anterior putamen, as
well as extension to the right putamen. On day 31 (4)
there was further extension of signal hyperintensities on
the right putamen as well as bilateral intensification of
signal hyperintensities on the heads of the caudate nu-
cleus and the left parietal cortex. One week later (5: day
38) signal intensification extended further down in both
putamen. The last MRI (6: day 48) performed six weeks
before death, showed extension of signal hyperintensi-
ties to the left frontal operculum and left temporal cor-
tex, as well as signal intensification of the previously de-
scribed lesions, especially those in both caudate nuclei,
both putamen, and the cerebellum. In contrast to a pre-
vious report [9], no significant visible atrophy was pres-
ent.
Neuropathological investigation
From the formalin fixed brain samples from 25 repre-
sentative levels of eleven regions of interest were taken
and were embedded in paraffin.These representative re-
gions included the frontal, temporal, parietal and occip-
ital cortical areas, hippocampus, basal ganglia, thala-
mus, mesencephalon and cerebellum, including vermis
(see Fig. 2).
Paraffin sections (5 µm thick) were stained with
Hematoxylin and Eosin (H&E), Van Gieson – luxol fast
blue, Thioflavin-S and with the Gallyas silver technique
for the demonstration of neurofibrillary tangles. For the
detection of prion protein (PrP), paraffin sections were
immunostained with a monoclonal antibody (clone
3F4), which recognizes amino acids 109–112 epitope of
the prion protein (PrP). In order to exclude Alzheimer’s
disease and the possibility of other neurodegenerative
disorders, further immunohistochemical investigations
were performed.
In addition to the presence of specific neuropatho-
logical changes (spongiosis,neuronal loss and gliosis) in
all cortical areas tested, the detection of PrP using 3F4
antibody definitely confirmed the clinical diagnosis of
sporadic CJD. A semiquantitative assessment of the
severity of spongiosis, neuronal loss and gliosis was per-
formed. The density of spongiosis was determined on
H&E-stained sections, the severity of neuronal loss on
H&E and synaptophysin immunostained sections using
monoclonal antibody, M0776, clone SY 38 (DAKO Cor-
poration, Carpinteria, California). The density of astro-
cytic gliosis was analysed on H&E and on immuno-
stained sections using anti glial fibrillary acidic protein
(GFAP) antibody (Z334, DAKO Corporation, Carpinte-
ria, California). The densities of neuronal loss, spongio-
sis and gliosis were graded from “0 to 3”(0: absent,1: low
density, 2: medium density, 3: high density). The semi-
quantitative analysis was performed in all brain regions
indicated in Fig. 2. The neuropathologist was blinded
about the imaging results.
The semiquantitative assessment of the severity of
spongiform alteration, neuronal loss and gliosis in sev-
eral brain regions performed by a pathologist, blinded
to the MRI results, were compared with the findings of
the last MRI-scan (day 48).
Statistics were performed for corresponding neu-
ropathological and MRI data, available for all 11 regions
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of interest. The degree of severity (0–3) of histopatho-
logical changes was correlated with the ADC coefficient
of the corresponding region using Spearman rank cor-
relation.
Results
There was a reduction in the apparent diffusion coeffi-
cient (ADC) in all regions with spongiform alterations
(Table 1). However, no correlation was found between
the degree of spongiform alterations and the decrease in
the ADC (correlation coefficient for spongiosis: 0.12,
neuronal loss: –0.28 and gliosis: –0.28). ADC was most
reduced in the basal ganglia (caudate nucleus and puta-
men) while spongiosis was more severe in the cortical
regions (central gyrus and temporal and parietal cortex,
Fig. 2). Gliosis and neuronal loss occurred at similar lev-
els in these regions, but were more severe in the frontal
and occipital cortex and the cerebellum.
Discussion
Our serial study consisted of six DWI MRI-scans over a
period of six weeks in a case of histologically confirmed
CJD, which fulfilled the current criteria for CJD in the
premortem phase and it shows two findings: a) during
the radiological follow-up consisting of six MRI scans in
the first six weeks after admission, the increasing inten-
sity and extension of these hyperintense signals corre-
lated with disease progression and revealed multifocal
regions of increased cortical signal intensity in basal
ganglia and cortical regions; b) there was no correlation
between the degree of radiological and histopathologi-
cal abnormalities.
Concerning the first result brain MRI may show focal
hyperintensities in T2-weighted images in the striatum
and thalamus [10, 11] and in the occipital gyri [12], and
hyperintensity in T1- and T2-weighted images in the
globus pallidus [7], but late in the disease. The CJD-spe-
cific hyperintensities detected by diffusion-weighted
MRI result from cell damage with characteristic vac-
uolization of the neuropil [8, 13] with vacuoles with a di-
ameter of less than 20 µm, gliosis [8, 13] or astrocytosis
[13] that provide restricted diffusion compared with
normal tissue [14], resulting in an increased DWI signal
[15]. DWI can therefore detect cortical areas affected by
CJD that appear normal in T1 and T2 studies [9, 16, 17].
The sites of the most pronounced lesions in our pa-
tient were similar to those previously reported, with in-
volvement of the caudate nucleus, putamen, and cere-
bral cortex [5, 18]. The images showed intensification,
expansion,and migration of cortical and deep matter le-
sions during the studied time-course (Fig. 1).
Concerning the second result, spongiform changes
and gliosis were present in all histologically examined
regions, with hyperintensity signals in DWI, due to a re-
duced ADC (Fig. 2). Comparison of the ADC and cellu-
lar damage as shown by histopathology showed corre-
sponding localizations but no quantitative relation in
terms of the degree of severity (Fig. 2).
The lack of a quantitative relationship between the
degree of severity of radiological and pathological ab-
normalities might indicate differences in the reflection
of cellular damage and changes in water diffusion in dif-
ferent brain regions by radiological images. Interest-
ingly the ADC is lowest in the basal ganglia (putamen 49,
caudate nucleus 62.1) but spongiosis, gliosis and neu-
ronal loss had only degree 2 using a score between 0–3
whereas in some cortical regions with a severity-degree
of 3 ADC was quite high (parietal left: 77.7, frontal left:
71.1). Compared with the study of Mittal et al. [14] who
reported a detailed correlation with Diffusion-Weighted
MRI with neuropathology in CJD, there might be
methodological differences in the measurement of the
raw data. It has to be taken into account that the score for
the grading of the severity of pathological lesions is a
semiquantitative score which depends on the observer.
We conclude that DWI-imaging is a non-invasive
technique for follow-up in premortem phase, but that
ADC measurement does not permit an estimate of the
degree of the severity of cellular damage. The pattern of
focal cortical involvement and the extension of the le-
sions from the left basal ganglia to the right basal gan-
glia might argue for spreading of damage per contigui-
tatem.
Table 1 Results of ADC and histopathological examination for 11 regions of in-
terest
DWI Pathology
Localization ADC SD Spongiosis Neuronal Loss Gliosis
Central Gyrus left 64.8 16.5 3 3 3
Frontal left 71.1 14.2 1 3 3
Temporal left 89.2 11.1 3 2 2
Hippocampus 86.6 9.9 2 1 1
Parietal left 77.7 23.0 3 3 3
Occipital left 76.0 18.8 2 3 3
Caudate nucleus 62.1 12.7 2 2 2
Putamen 49.0 4.6 2 2 2
Mesencephalon 78.6 10.4 1 0 1
Thalamus 76.5 7.1 2 2 2
Vermis 68.9 12.0 2 3 3
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